Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parentheticals)

v3.24.0.1
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Accounts receivable, net of allowance (in Dollars) $ 85 $ 105
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized: 10,000,000 10,000,000
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 75,703,100 75,154,495
Common stock, shares outstanding 75,703,100 75,154,495
Series A Preferred Stock    
Preferred stock, shares authorized: 1,684,375 1,684,375
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock    
Preferred stock, shares authorized: 1,580,790 1,580,790
Preferred stock, shares issued 926,942 926,942
Preferred stock, shares outstanding 926,942 926,942
Prferred stock, liquidation preference (in Dollars) $ 18,075 $ 18,075
Non-voting common stock    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 3,553,000 3,553,000
Common stock, shares issued 896 896
Common stock, shares outstanding 896 896